Characterization of metabolic profile of mosapride citrate in rat and identification of two new metabolites: Mosapride N-oxide and morpholine ring-opened mosapride by UPLC–ESI-MS/MS

作者: Xiaohong Sun , Lili Niu , Xiaoqin Li , Xiumei Lu , Famei Li

DOI: 10.1016/J.JPBA.2009.03.011

关键词:

摘要: Abstract The identification and structure elucidation of metabolites mosapride, a selective gastroprokinetic agent, was investigated in rats. After oral administration, samples rat urine, bile, feces plasma were collected analyzed by UPLC–ESI-MS/MS method. Altogether 18 detected at least 15 reported for the first time. Two new metabolites, mosapride N-oxide urine plasma, morpholine ring-opened feces, identified comparison with reference standards. One known major mammalian metabolite, des-p-fluorobenzyl also identified. molecular structures nine phase I six II elucidated based on characteristics their protonated ions, product ions chromatographic retention times. mainly transformed four main metabolism pathways, dealkylation, N-oxidation, ring cleavage hydroxylation, dealkylation as predominant metabolic pathway, while formed glucuronidation. relatively comprehensive pathway proposed.

参考文章(25)
T Nomiyama, Y Sekine, H Miyazaki, M Sakashita, S Harasawa, S Tanaka, T Miwa, T Yamaguchi, Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects. Drug Research. ,vol. 43, pp. 867- 872 ,(1993)
Yoshida K, Sekine Y, Itogawa A, Tagawa M, Miyazaki H, Matsumoto S, Fujii T, Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Drug Research. ,vol. 43, pp. 1095- 1102 ,(1993)
Hatoyama T, Sekine Y, Tagawa M, Miyazaki H, Matsumoto S, Fujii T, Absorption, distribution, metabolism and excretion of [carbonyl-14C]mosapride citrate after repeated oral administration in rats. Drug Research. ,vol. 43, pp. 1103- 1108 ,(1993)
Mei He, Takashi Ohrui, Takae Ebihara, Satoru Ebihara, Hidetada Sasaki, Hiroyuki Arai, Mosapride citrate prolongs survival in stroke patients with gastrostomy. Journal of the American Geriatrics Society. ,vol. 55, pp. 142- 144 ,(2007) , 10.1111/J.1532-5415.2006.01026.X
Hideki Asakawa, Isao Hayashi, Takeshi Fukui, Katsuo Tokunaga, Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy Diabetes Research and Clinical Practice. ,vol. 61, pp. 175- 182 ,(2003) , 10.1016/S0168-8227(03)00121-9
h. s. kim, h. park, j. h. lim, s. h. choi, c. park, s. i. lee, j. l. conklin, Morphometric evaluation of oesophageal wall in patients with nutcracker oesophagus and ineffective oesophageal motility. Neurogastroenterology and Motility. ,vol. 20, pp. 869- 876 ,(2008) , 10.1111/J.1365-2982.2008.01128.X
Xiao-Hong Sun, Feng Man, Li-Yan Pang, Gui-Hua Gao, Xiao-Qin Li, Xiu-Lan Qi, Fa-Mei Li, Fungal biotransformation of mosapride by Cunninghamella elegans Journal of Molecular Catalysis B-enzymatic. ,vol. 59, pp. 82- 89 ,(2009) , 10.1016/J.MOLCATB.2009.01.009
Zhi Liu, Ryuji Sakakibara, Takeo Odaka, Tomoyuki Uchiyama, Tomoyuki Uchiyama, Tatsuya Yamamoto, Takashi Ito, Masato Asahina, Kazuya Yamaguchi, Taketo Yamaguchi, Takamichi Hattori, Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in Parkinsonian patients Movement Disorders. ,vol. 20, pp. 680- 686 ,(2005) , 10.1002/MDS.20387
Monique P Curran, Dean M Robinson, Mosapride : In Gastrointestinal Disorders Drugs. ,vol. 68, pp. 981- 991 ,(2008) , 10.2165/00003495-200868070-00007